Genetic and molecular characterization of uveal melanoma cell lines
- PMID: 22236444
- PMCID: PMC3288394
- DOI: 10.1111/j.1755-148X.2012.00971.x
Genetic and molecular characterization of uveal melanoma cell lines
Abstract
The recent identification of frequent activating mutations in GNAQ or GNA11 in uveal melanoma provides an opportunity to better understand the pathogenesis of this melanoma subtype and to develop rational therapeutics to target the cellular effects mediated by these mutations. Cell lines from uveal melanoma tumors are an essential tool for these types of analyses. We report the mutation status of relevant melanoma genes, expression levels of proteins of interest, and DNA fingerprinting of a panel of uveal melanoma cell lines used in the research community.
Published 2012. This article is a US Government work and is in the public domain in the USA.
References
-
- BALLOU LM, LIN HY, FAN G, JIANG YP, LIN RZ. Activated G alpha q inhibits p110 alpha phosphatidylinositol 3-kinase and Akt. The Journal of biological chemistry. 2003;278:23472–9. - PubMed
-
- BEDIKIAN AY. Metastatic Uveal Melanoma Therapy: Current Options. International Ophthalmology Clinics. 2006;46:151–166. - PubMed
-
- CALIPEL A, LEFEVRE G, POUPONNOT C, MOURIAUX FDR, EYCHÃ̇NE A, MASCARELLI FDR. Mutation of B-Raf in Human Choroidal Melanoma Cells Mediates Cell Proliferation and Transformation through the MEK/ERK Pathway. Journal of Biological Chemistry. 2003;278:42409–42418. - PubMed
-
- CHATTERJEE R. Cases of Mistaken Identity. Science. 2007;315:928–931. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials